Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Zonagen (zona) - good buy? -- Ignore unavailable to you. Want to Upgrade?

To: khrnyc who wrote (1880)	1/21/1998 4:28:00 AM
From: Bill Wexler	Read Replies (2) \| Respond to of 7041

This looks like good news for longs! I think they should buy as much stock as possible! Two minor concerns I have with your post though: 1) I find it odd that you would pop in on the Zonagen board as your first post to SI. Interestingly enough, a very "reasonable" sounding individual just popped in to the AVNT board (his first post on SI also - what a coincidence) to play the devil's advocate. Guess what? Both of these stocks have been recommended as "strong sells" by Manuel Asensio. 2) There is zero evidence that phentolamine produces erections. By the way, Zorgniotti's patent covers every method of phentolamine delivery EXCEPT oral. In fact, he determined that oral delivery was actually inferior. So now I'm confused...how will this protect Zonagen's "competitive advantage" considering that they are touting an oral solution? Care to comment? Zonagen is a fraud and a scam.